GnRH agonist therapy as ovarian protectants in female patients undergoing chemotherapy: a review of the clinical data
{{output}}
Background: Cancer survival rates in young women are improving due to progress in treatment. This includes aggressive chemotherapy, a treatment that often poses a threat to fertility. GnRH agonists were proposed as ovarian protec... ...
